Fetal down syndrome screening: A cost effectiveness analysis of alternative screening programs

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 8, Issue 6, 1999, Pages 243-248

  Cusick, William ^a   Vintzileos, Anthony M ^b  

^a STAMFORD HOSPITAL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Cost effectiveness analysis; Fetal Down syndrome; Ultrasound

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DOWN SYNDROME; FETUS; HUMAN; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST;

ADULT; AMNIOCENTESIS; COST-BENEFIT ANALYSIS; DOWN SYNDROME; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MATERNAL AGE; PREGNANCY; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL; UNITED STATES;

EID: 0032705793     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.3109/14767059909020492     Document Type: Article

References (11)

1. Moser HW, Rame CT, Leonard CO. Mental retardation. In: Emery AFH, Rimoin DL, editors. Principles and practice of medical genetics. London: Churchill Livingstone; 1990. p 495-511.
2. Waitzman NJ, Romano PS, Scheffler RM. Estimates of the economic costs of birth defects. Inquiry 1994;31:188-205.
3. Benacerraf BR, Neuberg D, Bromley B, Frigoletto FD. Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med 1992;11:449-458.
4. Nadel AS, Bromley B, Frigoletto FD, Benacerraf BR. Can the presumed risk of autosomal trisomy be decreased in fetuses of older women following a normal sonogram? J Ultrasound Med 1995;14:297-302.
5. Nyberg DA, Luthy DA, Cheng EY, Sheley RC, Resta RG, Williams MA. Role of prenatal risk of autosomal trisomy be decreased in fetuses of older women following a normal sonogram? J Ultrasound Med 1995;14:297-302.
6. DeVote GR, Alfi O. The use of color Doppler ultrasound to identify fetuses at increased risk for trisomy 21: an alternative for high-risk patients who decline genetic amniocentesis. Obstet Gyneocl 1995;85: 378-386.
7. Vintzileos AM, Campbell WA, Rodis JF, Guzman ER, Smulian JC, Knuppel RA. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21. Obstet Gynecol 1996;87(6):948-952.
8. Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 1998;12(1):8-14.
9. Kellner LH, Weiss RR, Weiner Z, Neuer M, Martin GM, Schulman H, Lipper S. The advantages of using triple-marker screening for chromosomal abnormalities. Am J Obstet Gynecol 1995;172(3):831-836.
10. Haddow JE, Palomaki GE, Prenatal screening for Down syndrome. In: Simpson JL, Elias S, editors. Essentials of prenatal diagnosis. New York: Churchill Livingstone; 1993. p 105-220.
11. Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med 1994;330(16):1114-1152.